Roivant Sciences Ltd. - Immunovant Batoclimab Graves' Disease Proof-Of-Concept Study Remission Data Transcript

Group 1 - The call is focused on reviewing the data related to Immunovant's Graves' disease [2] - Stephanie Lee, COO of Roivant Platforms, and Matt Gline, CEO of Roivant, are presenting the updates [2] - Slides and press releases related to the updates are available on the company's investor relations website [3]